bioRxivEvolutionary Biology
Competing evolutionary paths in growing populations with applications to multidrug resistance
Abstract
Investigating the emergence of a particular cell type is a recurring theme in models of growing cellular populations. The evolution of resistance to therapy is a classic example. Common questions are: when does the cell type first occur, and via which sequence of steps is it most likely to emerge? For growing populations, these questions can be formulated in a general framework of branching processes spreading through a graph from a root to a target vertex. Cells have a particular fitness value on each vertex and can transition along edges at specific rates. Vertices represents cell states, say genotypes or physical locations, while possible transitions are acquiring a mutation or cell migration. We focus on the setting where cells at the root vertex have the highest fitness and transition rates are small. Simple formulas are derived for the time to reach the target vertex and for the probability that it is reached along a given path in the graph. We demonstrate our results on several scenarios relevant to the emergence of drug resistance, including: the orderings of resistance-conferring mutations in bacteria and the impact of imperfect drug penetration in cancer.
- organism: bacteria (other)
- organism: human
- research focus: host-pathogen & immune response
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Evolutionary rescue is promoted in compact cellular populations
- Phenotypic Heterogeneity Facilitates Survival While Hindering the Evolution of Drug Resistance Due to Intraspecific Competition
J. Guthrie, D. A. Charlebois·bioRxiv·Sep 20, 2021
- Drug-induced resistance evolution necessitates less aggressive treatment
T. Kuosmanen, J. Cairns, … V. Mustonen·bioRxiv·Oct 7, 2020
- Predicting trajectories and mechanisms of antibiotic resistance evolution
F. Pinheiro, O. Warsi, … M. Lässig·bioRxiv·Jul 2, 2020
- Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics and treatment regimens
C. Igler, J. Rolff, R. R. Regoes·bioRxiv·Oct 19, 2020
- Multi-scale predictions of drug resistance epidemiology suggest a new design principle for rational drug design.
S. Leighow, C. Liu, … J. R. Pritchard·bioRxiv·Sep 19, 2019